The Maynard Lab investigates immunobiological factors that contribute to cancer health disparities in racial/ethnic minorities and underserved populations. We use molecular pathology techniques to characterize the inflammatory landscape of prostate cancer and pancreatic cancer tissues from patients with varied genetic ancestry. We also use molecular and cellular biology methods to investigate the role of inflammation-associated P2 purinergic receptors in cancer initiation and aggressiveness. Finally, we use translational approaches aimed at therapeutically targeting P2 purinergic receptors in patients with cancer.
The Maynard Lab fosters diversity, advocates equity, promotes inclusion, and encourages self-care toward scientific excellence and human enrichment.